1 GABAPENTIN | 140 of 3,5100 | 4510 prescriptions Less than 1% of all prescriptions | 2130 | 900 patients 46% of all patients | 450 patients 23% of all patients | |
2 TIZANIDINE HCL | 200 of 1,1120 | 1930 prescriptions Less than 1% of all prescriptions | 700 | 430 patients 22% of all patients | 170 patients 9% of all patients | |
3 AMITRIPTYLINE HCL | 80 of 7970 | 920 prescriptions Less than 1% of all prescriptions | 350 | 170 patients 9% of all patients | < 11 | |
4 MELOXICAM | 810 of 1,8800 | 730 prescriptions Less than 1% of all prescriptions | 540 | 150 patients 8% of all patients | < 11 | |
5 BACLOFEN | 500 of 8160 | 660 prescriptions Less than 1% of all prescriptions | 230 | 130 patients 7% of all patients | < 11 | |
6 CYCLOBENZAPRINE HCL | 670 of 1,0680 | 460 prescriptions Less than 1% of all prescriptions | 240 | 180 patients 9% of all patients | < 11 | |
7 METHOCARBAMOL | 160 of 1850 | 370 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
8 DICLOFENAC SODIUM | 690 of 7400 | 330 prescriptions Less than 1% of all prescriptions | | 200 patients 10% of all patients | < 11 | |
9 NORTRIPTYLINE HCL | 270 of 1350 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
10 CHLORZOXAZONE | 60 of 180 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
11 PREDNISONE | 1140 of 2,2740 | 620 prescriptions Less than 1% of all prescriptions | 300 | 500 patients 25% of all patients | 230 patients 12% of all patients | |
12 IBUPROFEN | 840 of 9430 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 MOVANTIK (NALOXEGOL OXALATE) | 180 of 470 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 DOXEPIN HCL | 530 of 2580 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 OXYCONTIN (OXYCODONE HCL) | 50 of 60 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | O |
16 SUMATRIPTAN SUCCINATE | 310 of 1790 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |